ARCT Arcturus Therapeutics Holdings Inc.
Fundamentals / CIK 0001768224 / USDArcturus Therapeutics Holdings Inc. reported $30.51M in revenue and a net loss of $87.24M for the trailing twelve months ended September 30, 2026 (up 6.7% year over year), with a -311.2% operating margin.
Audited annual (10-K / 20-F) and quarterly (10-Q) statements parsed directly from SEC EDGAR CompanyFacts. Open ARCT in the Convexity terminal for live prices, valuation multiples, transcripts, and insider flow.
-
Revenue TTM$30.51M +6.7% YoY
-
Operating Income TTM-$94.97M -311.2% margin
-
Net Income TTM-$87.24M -285.9% net margin
-
Diluted EPS TTM-$3.07 Split-adjusted
-
Free Cash Flow TTM-$62.45M -204.7% FCF margin
-
Cash & ST Investments Sep 30, 2026$184.8M Total debt: $21.86M
Annual revenue and net income
8 fiscal years (2018 to 2025), reported in USD.
Financial statements and ratios
Reported in USD. Per-share figures and share counts are adjusted for stock splits from SEC filings.
Income Statement (Annual) · Reported in USD · Newest filing period first.
| Income Statement | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $82.03M | $152.3M | $166.8M | $206.0M | $12.36M | $9.54M | $20.79M | $15.75M |
| Research & Development | $112.2M | $195.2M | $192.1M | $147.8M | $173.8M | $57.85M | $33.64M | $16.98M |
| Total Operating Expenses | $158.3M | $248.0M | $245.0M | $193.8M | $215.2M | $81.06M | $46.30M | $37.56M |
| Operating Income | -$76.26M | -$95.67M | -$78.20M | $12.18M | -$202.9M | -$71.52M | -$25.51M | -$21.81M |
| EBITDA | -$73.23M | -$92.12M | -$75.25M | $13.70M | -$201.7M | -$70.64M | -$24.83M | -$21.23M |
| Income Before Tax | -$65.78M | -$80.94M | -$27.89M | $10.64M | -$203.7M | -$72.15M | -$25.99M | -$21.79M |
| Income Tax Expense | -- | -$4.0K | $1.83M | $1.29M | -- | -- | -- | -- |
| Net Income | -$65.78M | -$80.94M | -$29.73M | $9.35M | -$203.7M | -$72.15M | -$25.99M | -$21.79M |
| Basic EPS | -$2.40 | -$3.00 | -$1.12 | $0.35 | -$7.74 | -$3.55 | -$2.15 | -$2.16 |
| Diluted EPS | -$2.40 | -$3.00 | -$1.12 | $0.35 | -$7.74 | -$3.55 | -$2.15 | -$2.16 |
| Basic Shares Outstanding | 27.4M | 27.0M | 26.6M | 26.4M | 26.3M | 20.3M | 12.1M | 10.1M |
| Diluted Shares Outstanding | 27.4M | 27.0M | 26.6M | 27.1M | 26.3M | 20.3M | 12.1M | 10.1M |
Income Statement (Quarterly) · Reported in USD · Newest filing period first.
| Income Statement | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $18.30M | $2.96M | $2.06M | $7.20M | $17.15M | $28.30M | $29.38M | $22.77M |
| Research & Development | $17.00M | $17.52M | $21.53M | $24.48M | $23.27M | $29.58M | $34.89M | $43.78M |
| Total Operating Expenses | $27.48M | $28.50M | $30.99M | $38.50M | $33.66M | $39.92M | $46.21M | $56.16M |
| Operating Income | -$9.19M | -$25.55M | -$28.93M | -$31.31M | -$16.51M | -$11.62M | -$16.83M | -$33.39M |
| EBITDA | -$8.59M | -$24.95M | -$28.27M | -$30.62M | -$15.71M | -$10.82M | -$16.02M | -$32.58M |
| Income Before Tax | -$7.41M | -$23.79M | -- | -$29.08M | -$13.45M | -$9.18M | -$14.08M | -$30.01M |
| Income Tax Expense | $0 | $0 | -- | -- | $0 | $4.0K | $0 | -$4.0K |
| Net Income | -$7.41M | -$23.79M | -$26.96M | -$29.08M | -$13.45M | -$9.18M | -$14.08M | -$30.00M |
| Basic EPS | -$0.26 | -$0.84 | -$0.95 | -- | -$0.49 | -$0.34 | -$0.52 | -- |
| Diluted EPS | -$0.26 | -$0.84 | -$0.95 | -- | -$0.49 | -$0.34 | -$0.52 | -- |
| Basic Shares Outstanding | 28.4M | 28.4M | 28.4M | -- | 27.2M | 27.1M | 27.1M | -- |
| Diluted Shares Outstanding | 28.4M | 28.4M | 28.4M | -- | 27.2M | 27.1M | 27.1M | -- |
Balance Sheet (Annual) · Reported in USD · Newest filing period first.
| Balance Sheet | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 |
|---|---|---|---|---|---|---|---|---|
| Cash & Cash Equivalents | $230.9M | $237.0M | $292.0M | $391.9M | $370.5M | $462.9M | $71.35M | $36.71M |
| Cash & Short-Term Investments | $230.9M | $237.0M | $292.0M | $391.9M | $370.5M | $462.9M | $71.35M | $36.71M |
| Accounts Receivable, Net | $5.56M | $3.97M | $32.06M | $2.76M | $3.37M | $2.12M | $2.18M | $4.48M |
| Other Current Assets | -- | -- | -- | -- | -- | -- | $38K | $92K |
| Total Current Assets | $241.4M | $306.0M | $386.6M | $403.3M | $379.0M | $467.8M | $74.29M | $41.83M |
| Property, Plant & Equipment, Net | $6.74M | $9.53M | $12.43M | $12.41M | $5.64M | $3.38M | $2.35M | $1.98M |
| Total Non-Current Assets | $29.70M | $38.09M | $42.81M | $47.05M | $13.85M | $8.67M | $7.85M | $2.37M |
| Total Assets | $271.1M | $344.1M | $429.4M | $450.4M | $392.8M | $476.5M | $82.14M | $44.20M |
| Accounts Payable | $4.24M | $7.19M | $5.28M | $7.45M | $10.06M | $10.77M | $5.79M | $2.40M |
| Short-Term Debt | -- | -- | -- | $60.66M | $22.47M | $1.25M | -- | -- |
| Deferred Revenue (Current) | $8.25M | $19.51M | $44.83M | $28.65M | $43.48M | $18.11M | $8.40M | $6.27M |
| Total Current Liabilities | $36.38M | $65.49M | $81.99M | $127.0M | $99.54M | $49.52M | $21.32M | $12.58M |
| Long-Term Debt | -- | -- | -- | -- | $40.63M | $13.85M | $14.99M | $9.91M |
| Deferred Revenue (Non-Current) | -- | $12.60M | $42.50M | $20.07M | $19.93M | $12.51M | $15.18M | $7.53M |
| Other Non-Current Liabilities | -- | -- | $497K | $2.80M | -- | -- | -- | -- |
| Total Non-Current Liabilities | $20.78M | $37.60M | $68.90M | $53.09M | $65.07M | $30.38M | $35.03M | $17.98M |
| Total Liabilities | $57.16M | $103.1M | $150.9M | $180.1M | $164.6M | $79.90M | $56.35M | $30.56M |
| Total Debt (incl. Leases) | $25.00M | $28.55M | $30.22M | $94.75M | $69.15M | $20.75M | $20.67M | $9.91M |
| Common Stock | $28K | $27K | $27K | $27K | $26K | $26K | $15K | $214K |
| Retained Earnings | -$514.6M | -$448.8M | -$367.9M | -$338.1M | -$347.5M | -$143.8M | -$71.67M | -$44.87M |
| Total Stockholders' Equity | $214.0M | $241.0M | $278.5M | $270.3M | $228.2M | $396.6M | $25.79M | $13.64M |
| Total Equity | $214.0M | $241.0M | $278.5M | $270.3M | $228.2M | $396.6M | $25.79M | $13.64M |
Balance Sheet (Quarterly) · Reported in USD · Newest filing period first.
| Balance Sheet | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|---|---|---|---|
| Cash & Cash Equivalents | $184.8M | $191.5M | $211.4M | $230.9M | $180.4M | $196.5M | $216.9M | $237.0M |
| Cash & Short-Term Investments | $184.8M | $191.5M | $211.4M | $230.9M | $180.4M | $196.5M | $216.9M | $237.0M |
| Accounts Receivable, Net | $1.25M | $1.81M | $1.34M | $5.56M | $7.95M | $17.20M | $14.57M | $3.97M |
| Total Current Assets | $189.4M | $197.2M | $216.9M | $241.4M | $249.2M | $274.5M | $278.8M | $306.0M |
| Property, Plant & Equipment, Net | $4.81M | $5.36M | $6.08M | $6.74M | $7.42M | $8.09M | $8.87M | $9.53M |
| Total Non-Current Assets | $25.92M | $27.15M | $28.53M | $29.70M | $33.14M | $34.77M | $52.99M | $38.09M |
| Total Assets | $215.3M | $224.3M | $245.4M | $271.1M | $282.3M | $309.3M | $331.8M | $344.1M |
| Accounts Payable | $5.77M | $4.41M | $4.09M | $4.24M | $5.49M | $10.62M | $6.18M | $7.19M |
| Deferred Revenue (Current) | $419K | $6.28M | $7.61M | $8.25M | $6.83M | $11.26M | $12.67M | $19.51M |
| Total Current Liabilities | $28.34M | $33.54M | $34.37M | $36.38M | $31.70M | $46.52M | $49.41M | $65.49M |
| Long-Term Debt | -- | -- | -- | -- | -- | -- | $15.00M | -- |
| Deferred Revenue (Non-Current) | -- | -- | -- | -- | $4.22M | $8.77M | $9.63M | $12.60M |
| Total Non-Current Liabilities | $18.24M | $18.97M | $19.68M | $20.78M | $26.09M | $31.70M | $48.62M | $37.60M |
| Total Liabilities | $46.59M | $52.50M | $54.05M | $57.16M | $57.78M | $78.22M | $98.03M | $103.1M |
| Total Debt (incl. Leases) | $21.86M | $22.93M | $23.99M | $25.00M | $25.99M | $26.96M | $42.66M | $28.55M |
| Common Stock | $28K | $28K | $28K | $28K | $27K | $27K | $27K | $27K |
| Retained Earnings | -$572.8M | -$565.3M | -$541.6M | -$514.6M | -$485.5M | -$472.1M | -$462.9M | -$448.8M |
| Total Stockholders' Equity | $168.7M | $171.8M | $191.4M | $214.0M | $224.6M | $231.1M | $233.8M | $241.0M |
| Total Equity | $168.7M | $171.8M | $191.4M | $214.0M | $224.6M | $231.1M | $233.8M | $241.0M |
Cash Flow Statement (Annual) · Reported in USD · Newest filing period first.
| Cash Flow Statement | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 |
|---|---|---|---|---|---|---|---|---|
| Net Income | -$65.78M | -$80.94M | -$29.73M | $9.35M | -$203.7M | -$72.15M | -$25.99M | -$21.79M |
| Depreciation & Amortization | $3.02M | $3.54M | $2.96M | $1.53M | $1.19M | $882K | $684K | $582K |
| Stock-Based Compensation | $25.41M | $37.99M | $34.65M | $30.61M | $28.91M | $6.76M | $1.98M | $1.26M |
| Change in Receivables | -$1.59M | $28.09M | -$29.30M | $603K | -$1.24M | $54K | $2.30M | -$4.00M |
| Change in Payables | -$2.96M | $1.92M | -$2.24M | -$3.11M | -$769K | $4.81M | $3.15M | $578K |
| Operating Cash Flow | -$74.27M | -$59.75M | -$18.10M | $31.99M | -$135.0M | -$42.86M | -$6.45M | -$20.76M |
| Capital Expenditure | -$230K | -$648K | -$2.90M | -$7.73M | -$3.41M | -$1.74M | -$818K | -$1.48M |
| Free Cash Flow | -$74.50M | -$60.40M | -$21.00M | $24.27M | -$138.4M | -$44.60M | -$7.26M | -$22.24M |
| Investing Cash Flow | -$230K | -$648K | -$2.90M | -$7.73M | -$3.41M | -$1.74M | -$818K | $22.13M |
| Common Stock Issued | $11.69M | -- | -- | -- | -- | $423.8M | $21.28M | -- |
| Financing Cash Flow | $13.38M | $5.42M | -$24.09M | -$2.86M | $48.02M | $436.1M | $41.91M | $10.20M |
| Net Change in Cash | -$61.12M | -$54.98M | -$45.09M | $21.41M | -$90.43M | $391.5M | $34.64M | $11.58M |
Cash Flow Statement (Quarterly) · Reported in USD · Newest filing period first.
| Cash Flow Statement | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|---|---|---|---|
| Net Income | -$7.41M | -$23.79M | -$26.96M | -$29.08M | -$13.45M | -$9.18M | -$14.08M | -$30.00M |
| Depreciation & Amortization | $600K | $600K | $658K | $682K | $800K | $800K | $801K | $819K |
| Stock-Based Compensation | $4.04M | $4.23M | $4.33M | $6.82M | $5.73M | $6.20M | $6.66M | $8.98M |
| Change in Receivables | $564K | -$470K | $4.22M | $2.39M | $9.25M | -$2.63M | -$10.60M | $26.23M |
| Change in Payables | $1.35M | $321K | -$142K | -$1.34M | -$5.04M | $4.44M | -$1.01M | -$2.94M |
| Operating Cash Flow | -$6.91M | -$19.91M | -$19.44M | -$16.23M | -$17.15M | -$5.75M | -$35.14M | -$284K |
| Capital Expenditure | -$52K | $0 | $0 | $88K | -$181K | $0 | -$137K | $0 |
| Free Cash Flow | -$6.96M | -$19.91M | -$19.44M | -$16.14M | -$17.33M | -$5.75M | -$35.27M | -$284K |
| Investing Cash Flow | -$52K | $18K | $34K | $88K | -$181K | $0 | -$137K | $0 |
| Financing Cash Flow | $291K | $0 | $16K | $11.69M | $1.23M | -$14.73M | $15.20M | $134K |
| Net Change in Cash | -$6.67M | -$19.89M | -$19.39M | -$4.45M | -$16.11M | -$20.48M | -$20.08M | -$150K |
Margins, returns, leverage, liquidity, and year-over-year growth computed directly from SEC EDGAR statement levels. Multi-year figures show cumulative per-share growth.
| Ratios & Growth | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 |
|---|---|---|---|---|---|---|---|---|
| Operating Margin | -93.0% | -62.8% | -46.9% | 5.9% | -1641.3% | -749.8% | -122.7% | -138.5% |
| Net Profit Margin | -80.2% | -53.1% | -17.8% | 4.5% | -1648.0% | -756.3% | -125.0% | -138.3% |
| Return on Equity (ROE) | -30.7% | -33.6% | -10.7% | 3.5% | -89.2% | -18.2% | -100.8% | -159.7% |
| Return on Assets (ROA) | -24.3% | -23.5% | -6.9% | 2.1% | -51.8% | -15.1% | -31.6% | -49.3% |
| Current Ratio | 6.64x | 4.67x | 4.72x | 3.18x | 3.81x | 9.45x | 3.48x | 3.33x |
| Quick Ratio | 6.50x | 3.68x | 3.95x | 3.11x | 3.76x | 9.39x | 3.45x | 3.28x |
| Debt to Equity | 0.12x | 0.12x | 0.11x | 0.35x | 0.30x | 0.05x | 0.80x | 0.73x |
| Revenue Growth (YoY) | -46.1% | -8.7% | -19.0% | +1566.8% | +29.6% | -54.1% | +32.0% | -- |
| Operating Income Growth (YoY) | -- | -- | -742.2% | -- | -- | -- | -- | -- |
| Net Income Growth (YoY) | -- | -- | -417.9% | -- | -- | -- | -- | -- |
| EPS Growth (YoY) | -- | -- | -420.0% | -- | -- | -- | -- | -- |
| Operating Cash Flow Growth (YoY) | -- | -- | -156.6% | -- | -- | -- | -- | -- |
| Free Cash Flow Growth (YoY) | -- | -- | -186.5% | -- | -- | -- | -- | -- |
| 5Y Revenue / Share Growth | +537.6% | +227.5% | +300.4% | -- | -- | -- | -- | -- |
Quarterly margins, ROE, and ROA use trailing-twelve-month (TTM) flows summed across four contiguous quarters. Growth rates are true year-over-year comparisons against the same quarter a year earlier.
| Ratios & Growth | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|---|---|---|---|
| Operating Margin | -311.2% | -348.3% | -161.5% | -93.0% | -80.3% | -59.4% | -57.1% | -62.8% |
| Net Profit Margin | -285.9% | -317.6% | -143.8% | -80.2% | -68.3% | -49.3% | -47.5% | -53.1% |
| Return on Equity (ROE) | -51.7% | -54.3% | -41.1% | -30.7% | -29.7% | -26.0% | -29.2% | -33.6% |
| Return on Assets (ROA) | -40.5% | -41.6% | -32.1% | -24.3% | -23.6% | -19.5% | -20.6% | -23.5% |
| Current Ratio | 6.68x | 5.88x | 6.31x | 6.64x | 7.86x | 5.90x | 5.64x | 4.67x |
| Quick Ratio | 6.56x | 5.76x | 6.19x | 6.50x | 5.94x | 4.59x | 4.69x | 3.68x |
| Debt to Equity | 0.13x | 0.13x | 0.13x | 0.12x | 0.12x | 0.12x | 0.18x | 0.12x |
| Revenue Growth (YoY) | +6.7% | -89.5% | -93.0% | -68.4% | -58.8% | -43.2% | -22.7% | -26.2% |